MAb-3F8
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAb-3F8, covering 2013-03-08 to 2013-03-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients [Phase 2]